| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |